凝血与免疫疗法和BRAF/MEK抑制剂治疗的相互依赖:从前性研究中得出的结果

Malte Beckmann1, Julian Schlüter2, Michael Erdmann1

  • 1Department of Dermatology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), University Hospital Erlangen, Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nuremberg (FAU), 91054, Erlangen, Germany.

概括

免疫检查点抑制剂 (ICI) 和BRAF/MEK抑制剂可以诱导前凝血状态,增加复发风险. 凝血参数可能会影响ICI治疗在晚期皮肤癌患者的有效性.